LUPIN
Back to Balance Sheet
|
LUPIN Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹2,390 Cr | ₹820 Cr | ₹992 Cr | ₹1,153 Cr | ₹1,136 Cr |
What is the latest Total Non-Current Liabilities ratio of LUPIN ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹2,390 Cr |
| Mar2024 | ₹820 Cr |
| Mar2023 | ₹992 Cr |
| Mar2022 | ₹1,153 Cr |
| Mar2021 | ₹1,136 Cr |
How is Total Non-Current Liabilities of LUPIN Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,390 Cr | 191.57 | |
| Mar2024 | ₹820 Cr | -17.38 | |
| Mar2023 | ₹992 Cr | -13.96 | |
| Mar2022 | ₹1,153 Cr | 1.50 | |
| Mar2021 | ₹1,136 Cr | - | |
Compare Total Non-Current Liabilities of peers of LUPIN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LUPIN | ₹91,300.6 Cr | -2.4% | 3% | -0.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,370.0 Cr | 1.2% | 5.5% | 0.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,802.0 Cr | -1.8% | -3.1% | 8.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,841.0 Cr | -2% | 2.8% | 19.2% | Stock Analytics | |
| CIPLA | ₹121,481.0 Cr | -0.7% | -8.6% | 2.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,220.0 Cr | -1.5% | -4.3% | 2.5% | Stock Analytics | |
LUPIN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LUPIN | -2.4% |
3% |
-0.4% |
| SENSEX | -0.1% |
0.6% |
9.8% |
You may also like the below Video Courses